바이오마린제약(주)
MX ˙ BMV ˙ US09061G1013
SecurityMX:BMRN / BioMarin Pharmaceutical Inc.
InstitutionPoint72 Asset Management, L.P.
ManagerSteven Cohen
Latest Disclosed Ownership1,199,206 shares
Latest Disclosed Value $ 67,743,147
Point72 Asset Management, L.P. ownership in BMRN / BioMarin Pharmaceutical Inc.

On May 15, 2026 - Point72 Asset Management, L.P. filed a 13F-HR form disclosing ownership of 1,199,206 shares of BioMarin Pharmaceutical Inc. (MX:BMRN) valued at $67,743,147 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 438,817 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of 173.28% during the quarter.

Point72 Asset Management, L.P. has a history of taking positions in derivatives of the underlying security (BMRN) in the form of stock options. The firm currently holds call options representing 100,000 of underlying shares valued at $5,649,000 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:BMRN / BioMarin Pharmaceutical Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,199,206 760,389 173.28 67,743 159.77 0.0868
2026-02-17 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 438,817 438,817 26,079 0.0292
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -395,750 -100.00 0 -100.00
2025-07-21 2025-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 395,750 129,314 48.53 27,976 59.75 0.0639
2025-05-15 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 395,750 129,314 27,976 0.0639
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 266,436 68,718 34.76 17,513 26.01 0.0386
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 197,718 197,718 13,898 0.0353
2024-09-16 2024-06-30 13F/A-2 BIOMARIN PHARMACEUTICAL COM 09061G101 0 -1,345,720 -100.00 0 -100.00
2024-08-19 2024-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 0 0
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 0
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,345,720 890,420 195.57 117,535 167.73 0.2849
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 455,300 455,300 43,900 0.1062
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -716,700 -100.00 0 -100.00
2023-05-15 2022-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 716,700 121,300 20.37 74,171 46.95 0.2521
2023-02-14 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 716,700 121,300 74,171 0.2521
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 595,400 447,529 302.65 50,472 311.88 0.2016
2022-08-15 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 147,871 -218,965 -59.69 12,254 -56.67 0.0517
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 366,836 -454,960 -55.36 28,283 -61.05 0.1123
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 821,796 30,007 3.79 72,606 18.64 0.2899
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 791,789 425,289 116.04 61,197 100.11 0.2688
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 366,500 110,000 42.88 30,581 57.89 0.1374
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 256,500 -124,600 -32.69 19,368 -42.04 0.0905
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 381,100 -562,593 -59.62 33,419 -53.45 0.1630
2020-11-16 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 943,693 943,693 71,796 0.3676
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -260,683 -100.00 0 -100.00
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 260,683 196,010 303.08 22,041 405.64 0.1159
2019-11-15 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 64,673 -186,973 -74.30 4,359 -79.78 0.0268
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 251,646 251,646 21,553 0.1128
2018-11-14 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -53,703 -100.00 0 -100.00
2018-08-14 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 53,703 -198,397 -78.70 5,059 -75.25 0.0202
2018-05-15 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 252,100 -245,249 -49.31 20,438 -53.92 0.0854
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 497,349 -272,193 -35.37 44,349 -38.08 0.1914
2017-11-14 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 769,542 769,542 71,621 0.3196
2017-08-14 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -364,800 -100.00 0 -100.00
2017-05-15 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 364,800 -161,800 -30.73 32,022 -26.60 0.1785
2017-02-14 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 526,600 372,900 242.62 43,624 206.78 0.3050
2016-11-14 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 153,700 153,700 0.00 14,220 0.1000
2015-05-15 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -74,600 -100.00 0 -100.00
2015-02-17 2014-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 74,600 -601,000 -88.96 6,744 -86.17 0.0473
2014-11-14 2014-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 675,600 585,500 649.83 48,751 769.78 0.3669
2014-08-14 2014-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 90,100 90,100 5,605 0.0359
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 100,000 5,649 n/a n/a n/a
2025-07-21 2025-03-31 13F/A BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 0 n/a n/a n/a
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 300,000 0.00 19,719 -6.49 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 300,000 21,087 n/a n/a n/a
2022-08-15 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 84,900 6,546 n/a n/a n/a
2018-05-15 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 883,400 176.93 78,773 165.33 n/a n/a n/a
2017-11-14 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 319,000 29,689 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.